This is going to be fun. As the science of the pipleline continues to prove itself, the cost of doing business with AMBS will go up daily. If BP wants to play chicken until revenue hits, I agree, so be it. I believe it could cost them more. Especially if more than one BP wants in. I can deal with a bidding war.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links